| Tag | Content |
|---|
EnhancerAtlas ID | HS012-17641 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr21:44487860-44488610 |
Target genes | |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr21:44487862-44487880 | CCTTCCTGCCTCCCTCCG | - | 6.15 | | HNF4G | MA0484.1 | chr21:44488365-44488380 | TCAGTTCAAAGGTCA | + | 6.03 | | Nr2f6 | MA0677.1 | chr21:44488366-44488380 | CAGTTCAAAGGTCA | + | 6.58 | | Rxra | MA0512.2 | chr21:44488366-44488380 | CAGTTCAAAGGTCA | + | 6.89 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_41747 | chr21:44483343-44488686 | LNCaP | | SE_68804 | chr21:44486615-44488728 | H9 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH21I043066 | chr21 | 44486616 | 44488728 |
|
Enhancer Sequence | ACCCTTCCTG CCTCCCTCCG AACTCACTTG GCCTTGGTCA TCTGAAATAC GAAATTCCGT 60
CCCCGCCTTG TCCCCAAGGC CTCTGCACCC ACAGCTTTCT CTGTGACGAT GCTGAGGTCT 120
ACCAGGGCTC TGCGCTCTTG GTGAAGAGCG ACCCTTAGGA ATTCCCTCCA CGTTCTTGAG 180
CCTGGAAACT GCGTCCTGCA AAGAAATGCC CTTCCCCGGA GGCCTCAGAC CACACCTCAG 240
GTGACCCCCT GCGCACCCAG GACGAGGCCA GCCACAGACC CTCCAAATTC CCATTCTCTG 300
TCTCATAAAT GATGAGCTGA ACTATCTGTC CCCACGAAGC TGGCAAGACA GAGGTAACCG 360
CTCCCTGGAC AGCGGGTGGC TCACAGCACG TGCTAGGACC CGTCCACTGC TCCTTAGCAG 420
GCATGACGCT AACCCTCCCC ACCTGCTTGC TTCTGCCTTT GACCCTCACC CGGCCCTTCA 480
CACCCTCGCT GCTTCCACTC CGGCCTCAGT TCAAAGGTCA CCTGTTCGTT CCCTGGTCCA 540
TCTGCTGGGG AGTCACTTTG GTCACCCTCT GACACAATGC CCTGTTGTGT GTTTTTCCCA 600
AACTTAAGCT GATATGTTCT TGGCCACTCA TTAACCAGCG AGTTTTCTGA TCCCAGGGCC 660
TTGCCTAAGG GATCCATCCC AGGACCCCCC AGGACCCCCC AGGCCCACGG AGCCCAGTGT 720
AGATGGAGGA AGCCCCTCTC CAAAGCCAGG 750
|
